ArticleMolecular therapy oncolytics2020

Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.

Jérémy Béguin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.